Importance Recommendations for additional doses of COVID-19 vaccines for people with
HIV (PWH) are restricted to those with advanced disease or unsuppressed HIV viral load …

Importance Understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19)
breakthrough illness among people with HIV (PWH) can inform vaccine guidelines and risk …

Objectives: Coronavirus disease 2019 (COVID-19) vaccination is reportedly efficient in
people with HIV (PWH) but vaccine trials included participants with normal CD4+ T-cell …

Introduction: Scaling up vaccination against COVID-19 is central to controlling the COVID-19
epidemic in the United States. Several vaccines are now approved for the prevention of …

COVID-19 vaccination is recommended for people living with HIV (PLWH), among whom
social inequities and co-morbidities may drive risks of COVID-19 infection and outcome …

Importance Data are limited on whether patients with breakthrough COVID-19 infection have
the potential to significantly contribute to the spread of SARS-CoV-2. Objective To compare …

Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …

The administration of COVID-19 vaccines is the primary strategy used to prevent further
infections by COVID-19, especially in people living with HIV (PLWH), who are at increased …

Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …

Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …